Abstracts

1278 – Acceptability of Doxycycline as Post-Exposure Prophylaxis in Southeastern Louisiana

Background Louisiana ranks first in the nation for chlamydia incidence and third for gonorrhea, necessitating effective prevention strategies for sexually transmitted infections (STIs). Doxycycline post-exposure prophylaxis (doxy PEP) has emerged as a promising prevention strategy, but its success relies on acceptability among healthcare providers and clients. In particular, it is important to understand acceptability of…

1239 – Syphilis Screening in Hospitalized People With HIV: A Key Strategy to Tackle HIV and STI Epidemics

Background Active sexually transmitted infections (STI) elevate the risk of HIV acquisition, highlighting the need for timely diagnosis and treatment to address the intertwined HIV/STI epidemics. Latin America bears a disproportionate burden of STIs, with sexual and gender minorities most affected. In recent years, Brazil has experienced a concerning rise in acquired/congenital syphilis cases, particularly…

1279 – Factors Influencing Doxy-PEP Awareness Among Sexual/Gender Minorities: A Web-Based Survey in Brazil

Background Sexual and gender minorities (SGM) face a disproportionate burden of sexually transmitted infections (STIs) worldwide, particularly in Latin America. While doxycycline post-exposure prophylaxis (doxy-PEP) is recommended in some countries to prevent bacterial STIs, no official guidelines or implementation studies have been conducted in any country of the Global South. This study aims to identify…

1284 – Antimicrobial Consumption Among Users of Doxycycline Postexposure Prophylaxis in Milan, Italy

Background Aim is to evaluate the changes in antimicrobial consumption of ceftriaxone, benzylpenicillin and doxycycline for the treatment of bacterial sexually transmitted infections (bSTIs), after the prescription of doxycycline post-exposure prophylaxis (DoxyPEP) among men who have sex with men (MSM). Methods Retrospective study of MSM in care for HIV or HIV pre-exposure prophylaxis (PrEP) at…

1287 – Prevalence of Tetracycline-Resistant Gonorrhea in British Columbia’s HIV Treatment and PrEP Program

Background British Columbia’s (BC) publicly-funded HIV treatment (HIV Tx) has been available since 1992, and HIV Pre-Exposure Prophylaxis (PrEP) for key populations since 2018. On 1-Dec-2023, a doxycycline for bacterial sexually transmitted infection (b-STI) initiative (Doxy-P) was launched among HIV Tx and PrEP clients, enrolling >3000 clients in 9 months. In light of increasing use…

1256 – Multipurpose Vaginal Rings: Preferences From a National Discrete Choice Survey With US Women

Background Women worldwide need and want multipurpose prevention technologies (MPTs) to meet their varied sexual-reproductive health needs. Most MPTs in development are vaginal rings. We assessed US women’s preferences re: specific ring attributes, to optimize a nonhormonal MPT ring in development to prevent pregnancy, HIV, other sexually transmitted infections (STIs), and bacterial vaginosis (BV). Methods We conducted a…

1283 – Topical Doxycycline Inserts Show High Efficacy Against Vaginal Chlamydia Acquisition in Macaques

Background Bacterial STIs are on the rise globally. Fast-dissolving dual-compartment (vaginal/rectal) inserts containing doxycycline (DOX) provide an alternate approach to STI prevention that can maximize local DOX concentrations while minimizing systemic distribution.   Here, we performed preclinical studies to evaluate the pharmacokinetics (PK) and protective efficacy following vaginal administration of CONRAD-developed inserts containing DOX against vaginal C.…